EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 3.0

The Mechanisms of the RANK/RANKL Pathway in COPD Pathogenesis with a Focus on Skeletal Muscle Dysfunction

Jun Wang iD, Qian Gao iD, Xiaoyu Han iD, Weibing Wu iD

International Journal of Chronic Obstructive Pulmonary Disease · 2026-11 · Volume 21 · 1-15

DOI: 10.2147/copd.s644331 ↗

At a glance

Übersichtsarbeit in International Journal of Chronic Obstructive Pulmonary Disease, 2026-11. Written by Jun Wang and 3 co-authors. Institution: School of Exercise and Health, Shanghai University of Sport, Shanghai, People's Republic of China. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Muscle, Skeletal, Receptor Activator of Nuclear Factor-kappa B, RANK Ligand. The full text is freely available (open access, CC BY-NC 3.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Chronic obstructive pulmonary disease (COPD) is a heterogeneous pulmonary disorder characterized by persistent respiratory symptoms and significant extrapulmonary complications. Skeletal muscle dysfunction, a prominent comorbidity, severely compromises exercise capacity and quality of life and independently predicts mortality. While pharmacological therapies effectively control respiratory symptoms, they have limited efficacy against COPD-associated muscle atrophy and functional decline, and the underlying mechanisms remain poorly understood. The RANK/RANKL signaling pathway, a key mediator of muscle-bone crosstalk, is markedly upregulated in COPD and contributes to its musculoskeletal pathology. This review synthesizes current knowledge on the RANK/RANKL pathway in COPD, with a dedicated focus on its mechanistic role in driving skeletal muscle pathology. We emphasize the pathway's role in driving proteolysis via the NF-κB/ubiquitin-proteasome system, impairing myogenic regeneration, sustaining chronic low-grade inflammation, and dysregulating metabolic and calcium homeostasis. These multifaceted pathological effects enable the RANK/RANKL pathway to bridge pulmonary inflammatory injury to peripheral skeletal muscle wasting, thereby representing a plausible therapeutic target to mitigate COPD-related systemic myopathy beyond conventional pulmonary-directed treatments.

Subjects

MeSH terms (MEDLINE)

Pulmonary Disease, Chronic ObstructiveMuscle, SkeletalReceptor Activator of Nuclear Factor-kappa BRANK LigandMuscular AtrophyLungHumansSignal TransductionAnimalsNF-kappa B

Author keywords

NF-kappa BRANK/RANKL signalingchronic obstructive pulmonary diseasemuscular atrophyubiquitin

Substances

Receptor Activator of Nuclear Factor-kappa BRANK LigandTNFSF11 protein, humanTNFRSF11A protein, humanNF-kappa B

Authors and institutions

  • School of Exercise and Health, Shanghai University of Sport, Shanghai, People's Republic of China.
  • College of Physical Education, Dalian University, Dalian, People's Republic of China.

ORCID profiles: Jun Wang, Qian Gao, Xiaoyu Han, Weibing Wu

Cite

APA

Wang, J., Gao, Q., Han, X., & Wu, W. (2026). The Mechanisms of the RANK/RANKL Pathway in COPD Pathogenesis with a Focus on Skeletal Muscle Dysfunction. International Journal of Chronic Obstructive Pulmonary Disease, Volume 21, 1-15. https://doi.org/10.2147/copd.s644331

Vancouver

Wang J, Gao Q, Han X, Wu W. The Mechanisms of the RANK/RANKL Pathway in COPD Pathogenesis with a Focus on Skeletal Muscle Dysfunction. International Journal of Chronic Obstructive Pulmonary Disease. 2026;Volume 21:1-15. doi:10.2147/copd.s644331

BibTeX
@article{Wang2026,
  author = {Wang, Jun and Gao, Qian and Han, Xiaoyu and Wu, Weibing},
  title = {The Mechanisms of the RANK/RANKL Pathway in COPD Pathogenesis with a Focus on Skeletal Muscle Dysfunction},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2026},
  volume = {Volume 21},
  pages = {1--15},
  doi = {10.2147/copd.s644331}
}
Start for free →